Gvk Biosciences

The government is seeking "legal advice" to deal with the recent ban imposed by the European Union on 700 medicines which were clinically tested by GVK Biosciences, a top official said.

After a gap of about two years, India and the European Union were expected to resume negotiations on August 28 on the proposed free trade agreement to boost two-way commerce and investment.

The largest EU-wide suspension of sales and distribution of generic drugs ordered by the European Commission will come into effect on August 21 and it will be applicable to all 28 member nations, according to Germany's drug regulator, the Federal Institute for Medicines and Medical Products (BfArM).

The action by the United Nations health agency follows an earlier scandal over drug testing at GVK Biosciences, which resulted in approvals for hundreds of generic drugs being withdrawn in Europe.

This is the first pact the city-based clinical research the company has inked after it got involved in regulatory issues with European Medicines Agency a few months ago.

Europe's drug regulator said on Friday it had recommended the suspension of a number of drugs which were approved on the basis of clinical studies conducted at GVK Biosciences in Hyderabad, India.

The Federal Institute for Drugs and Medical Devices said yesterday it had ordered drug manufacturers, wholesale dealers, medical stores and other outlets not to sell or use these medicines any longer.

A fire broke out at a facility of GVK Biosciences (GVK BIO), a drug discovery research and development organisation, in Hyderabad on Monday, officials said.

The government is seeking "legal advice" to deal with the recent ban imposed by the European Union on 700 medicines which were clinically tested by GVK Biosciences, a top official said.

After a gap of about two years, India and the European Union were expected to resume negotiations on August 28 on the proposed free trade agreement to boost two-way commerce and investment.

The largest EU-wide suspension of sales and distribution of generic drugs ordered by the European Commission will come into effect on August 21 and it will be applicable to all 28 member nations, according to Germany's drug regulator, the Federal Institute for Medicines and Medical Products (BfArM).

The action by the United Nations health agency follows an earlier scandal over drug testing at GVK Biosciences, which resulted in approvals for hundreds of generic drugs being withdrawn in Europe.

This is the first pact the city-based clinical research the company has inked after it got involved in regulatory issues with European Medicines Agency a few months ago.

Europe's drug regulator said on Friday it had recommended the suspension of a number of drugs which were approved on the basis of clinical studies conducted at GVK Biosciences in Hyderabad, India.

The Federal Institute for Drugs and Medical Devices said yesterday it had ordered drug manufacturers, wholesale dealers, medical stores and other outlets not to sell or use these medicines any longer.

A fire broke out at a facility of GVK Biosciences (GVK BIO), a drug discovery research and development organisation, in Hyderabad on Monday, officials said.